Daiwa Securities Group Inc. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16
-57.9%
4190.0%0.00%
Q2 2023$38
+31.0%
419
-5.8%
0.00%
Q1 2023$29
+26.1%
4450.0%0.00%
Q4 2022$23
-99.9%
445
+12.1%
0.00%
Q3 2022$27,000
+50.0%
3970.0%0.00%
Q2 2022$18,000
+20.0%
397
+33.2%
0.00%
Q1 2022$15,000
+7.1%
2980.0%0.00%
Q4 2021$14,000
+40.0%
2980.0%0.00%
Q3 2021$10,0000.0%298
+87.4%
0.00%
Q2 2021$10,000
+42.9%
1590.0%0.00%
Q1 2021$7,000
-12.5%
159
+12.0%
0.00%
Q4 2020$8,000
-38.5%
142
-66.1%
0.00%
Q3 2020$13,000
+18.2%
4190.0%0.00%
Q2 2020$11,0000.0%4190.0%0.00%
Q1 2020$11,0000.0%419
+16.1%
0.00%
Q4 2019$11,000
+10.0%
361
-9.3%
0.00%
Q3 2019$10,0000.0%3980.0%0.00%
Q2 2019$10,000
+42.9%
398
+11.2%
0.00%
Q1 2019$7,0000.0%358
-28.4%
0.00%
Q4 2018$7,0005000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders